ストックスクリーナーアプリを入手
101.32
2.47%
-2.57
アフターアワーズ：
102.45
1.13
+1.12%
Incyte Corp (INCY) 最新ニュース
Is Incyte Corporation (ICY) stock considered safe havenTrade Analysis Report & Verified Stock Trade Ideas - newser.com
Incyte to Present at Upcoming Investor Conferences - Yahoo Finance
Is Incyte Corporation (ICY) stock among top earnings playsPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - newser.com
Incyte at Jefferies London: Strategic Shift to Diversification - Investing.com
Incyte Expands ‘Moments of Clarity’ With New Stories Spotlighting Chronic Skin Conditions - MyChesCo
Incyte Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
VP Denton Files To Sell 278 Of Incyte Corp [INCY] - TradingView
Is Incyte Corporation building a consolidation baseEarnings Recap Report & Verified Chart Pattern Signals - newser.com
Incyte (INCY) Receives Positive Opinion for Minjuvi in Europe - GuruFocus
(tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL) - Business Wire
Can Incyte Corporation (ICY) stock attract analyst upgradesEarnings Trend Report & Reliable Entry Point Trade Alerts - newser.com
Forecasting Incyte Corporation price range with options dataJuly 2025 Outlook & Fast Entry High Yield Tips - newser.com
STATE STREET CORP Reduces Stake in Incyte Corp: A Strategic Port - GuruFocus
What risks investors should watch in Incyte Corporation stockTreasury Yields & AI Powered Market Entry Ideas - newser.com
Incyte Corp. stock underperforms Friday when compared to competitors - MarketWatch
Incyte Corp. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Key metrics from Incyte Corporation’s quarterly dataJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Why Analysts See Incyte’s Story Shifting as Pipeline Progress Drives New Valuation Targets - Yahoo Finance
Incyte Corporation (INCY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Incyte Corporation stock see PE expansionQuarterly Growth Report & Weekly High Return Opportunities - newser.com
Incyte Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Incyte Prepares to Showcase Pipeline Momentum With New mutCALR Data at ASH 2025 - MyChesCo
Incyte (INCY): Exploring Valuation After Recent Share Price Rally and Pipeline Progress - Yahoo Finance
Incyte stock hits 52-week high at 108.81 USD By Investing.com - Investing.com Canada
Incyte stock hits 52-week high at 108.81 USD - Investing.com
Peering Into Incyte Corp's Recent Short Interest - Benzinga
Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains - 富途牛牛
Prelude Therapeutics Reshapes Pipeline With Incyte Deal and Strategic Refocus - MyChesCo
Prelude Strikes $910 Million Deal With Incyte for Groundbreaking JAK2 Cancer Therapy - MyChesCo
Incyte (NASDAQ:INCY) Q3 Earnings: Leading The Immuno-Oncology Pack - Yahoo Finance
Incyte at Guggenheim Conference: Strategic Focus on Innovation - Investing.com
Can Incyte Corporation stock hit record highs again2025 Performance Recap & Real-Time Volume Analysis - newser.com
Published on: 2025-11-10 05:29:16 - newser.com
Can Incyte Corporation stock deliver sustainable ROEMarket Growth Report & Reliable Price Action Trade Plans - newser.com
Incyte Posts 20% Revenue Growth, Raises 2025 Outlook on Strong Drug Demand - MyChesCo
Incyte and Enable Injections Join Forces to Advance At-Home Cancer Treatments - MyChesCo
Incyte to Highlight Innovation at Major Global Healthcare Conferences in November - MyChesCo
Prelude Therapeutics (PRLD): Valuation Snapshot Following Incyte Deal and Pipeline Realignment - Yahoo Finance
Will Incyte Corporation stock outperform Dow Jones indexBull Run & Weekly High Momentum Picks - newser.com
How Incyte Corporation stock responds to policy changesWeekly Trend Report & Smart Money Movement Alerts - newser.com
Incyte boosts annual sales forecast of blood cancer drug after strong quarter - MSN
[Form 4] INCYTE CORP Insider Trading Activity - Stock Titan
Incyte EVP Denton sells $60,613 in stock By Investing.com - Investing.com South Africa
Incyte EVP Denton sells $60,613 in stock - Investing.com India
Will Incyte Corporation (ICY) stock return to pre crash levels2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Is It Time to Reevaluate Incyte After Strong Pipeline Update and 52% Price Surge? - Yahoo Finance
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema - The Joplin Globe
Leading vs lagging indicators on Incyte Corporation performanceJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Incyte (INCY): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
Incyte (NASDAQ:INCY) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Incyte stock hits 52-week high at 103.93 USD - Investing.com
Prelude Therapeutics (PRLD) Is Up 14.3% After Incyte Option Deal and Pipeline Shift Has the Bull Case Changed? - Yahoo Finance
Incyte Unveils Game-Changing mCALR Trials – What It Means for Blood Cancer Treatment! - Smartkarma
0.07%
0.82%
大文字化:
|
ボリューム (24 時間):